Status:

COMPLETED

a Retrospective Study on the Systemic Treatment of LPP and FFA

Lead Sponsor:

Erasmus Medical Center

Conditions:

Cicatricial Alopecia

Lichen Planopilaris

Eligibility:

All Genders

18+ years

Brief Summary

This retrospective study aims to assess the effectiveness of systemic treatments for lichen planopilaris (LPP) and frontal fibrosing alopecia (FFA) in patients treated at the Erasmus MC University Med...

Detailed Description

Cicatricial alopecia, also known as scarring alopecia, refers to a group of rare chronic inflammatory hair disorders resulting in irreversible hair loss. Lichen planopilaris (LPP) and frontal fibrosin...

Eligibility Criteria

Inclusion

  • Diagnosis of LPP or FFA
  • 18 years or older

Exclusion

  • Other forms of cicatricial alopecia than LPP or FFA

Key Trial Info

Start Date :

September 23 2022

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

February 1 2023

Estimated Enrollment :

315 Patients enrolled

Trial Details

Trial ID

NCT06512766

Start Date

September 23 2022

End Date

February 1 2023

Last Update

July 22 2024

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Erasmus MC

Rotterdam, South Holland, Netherlands, 3015GD